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Diroﬁlaria (Nochtiella) repens is a ﬁlarioid parasite that causes subcutaneous diroﬁlariosis in dogs. Adults, while localized in
subcutaneous tissues, lay embryos (microﬁlariae (mf)) into the blood stream of dogs, which constitute a reservoir for infection
of other deﬁnitive or accidental hosts as humans. This study was carried out to assess the eﬃcacy of spot-on combination of
imidacloprid and moxidectin on microﬁlariaemia in naturally infected dogs. A group of 11 dogs was monthly examined for
the presence of microﬁlariae in peripheral blood by modiﬁed Knott’s test method. Treatment was administered monthly for 4
months. All dogs (i.e., 100%) became negative for microﬁlariaemia throughout the study. These results conﬁrm the eﬀect of the
combinationof imidacloprid and moxidectin on D. (Nochtiella) repens.
1.Introduction
Diroﬁlaria (Nochtiella)repens isaﬁlarioidnematodeofgenus
Diroﬁlaria that belongs to family Onchocercidae of the order
Spirurida. Adults are mainly found in subcutaneous tissues
where they may cause diﬀerent clinical signs, such as dermal
swelling, subcutaneous nodules, or pruritus [1].
Embryos are released into the blood stream by gravid
female parasites and are ingested by mosquitoes during the
blood meal. Over 60 mosquito species belonging to genus
Anopheles, Culex, and Aedes could serve as vectors and
produce infective (L3) larvae [2, 3]. Development of L3 is
a temperate-dependent process, and climatic changes in last
years enable the spread of canine subcutaneous diroﬁlariosis
(CSD) from tropic and subtropics regions to temperate
zone countries [4] such as Czech Republic [5], Slovakia [6],
Hungary [7], and Austria [8].
Together with the spread of endemic CSD, there is an
increase intransmission ofD. repens, eventohumans. People
serve as occasional hosts in which aberrant migration of
t h el a r v a ec a nc a u s ed i ﬀerent clinical signs [9]. Location of
worms in the body can vary; nodules are found in subcuta-
neous tissue [10], lungs [9, 11] or conjunctival tissue [12].
Their importance in the case of diﬀerential diagnosis of
human neoplasia is high, and several authors described
human diroﬁlariosis as emerging disease [9, 11].
This implies that the management of CSD has high
importance in the prevention of human infections by D.
repens. Individual cases of CSD treatment were described
[1, 13]. Field study for elimination of D. repens microﬁlariae
in dogs using combination of moxidectin and imidacloprid
was described [14]. The study describes speciﬁc protocol for
D. repens infection treatment in dogs by commercial spot-on
product (Advocate, Bayer).
2.Materialsand Methods
2.1. Animals and Treatment. Atotalof11dogswere included
in this study during the monitoring of Diroﬁlaria spp.
infection in the southeastern area of the Czech Republic
through years 2009/2010. The group was composed of
outdoor-living dogs of various breeds, age, and gender,
which were tested positive for D. repens mf.
D. repens mf positive dogs were diagnosed after ﬁrst
blood sampling (examination no. 1). Consequently, after a2 Veterinary Medicine International
Table 1: The inﬂuence of Advocate on the presence of Diroﬁlaria repens microﬁlariae in the blood of tested dogs.
Examination† Treatment††
Number of microﬁlariae/mL blood
———————————
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11
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Dog 1
—
0
Dog 2
—
0
Dog 3
—
0
Dog 4
—
0
Dog 5
—
0
Dog 6
—
0
Dog 7
—
0
Dog 8
—
0
Dog 9
—
0
Dog 10
—
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†Examinations were performed monthly (in one month interval).
††TreatmentwithAdvocate,Bayer(imidaclopridat10–25mg/kgandmoxidectionat2.5–6,5mg/kg)monthlyforfourmonths(—notreatment,
√
treatment).
second blood sampling, dogs were treated following manu-
facturer’s instructions bycombinationofimidacloprid(min-
imum dosage 10mg/kg, max. 25mg/kg) and moxidection
(min. dosage 2.5, max. 6.25mg/kg) in spot-on (Advocate,
Bayer). Treatment was given monthly for 4 consecutive
months. After the end of treatment, blood sampling and mf
examination continued for 6 months. In total, this clinical
study lasted 11 months. According to the owners, no other
drug was given 5 months before and through the entire
study.
2.2. Sampling and Examination. Peripheral venous blood
(3mL) was collected every month from each dog (vena
cephalica antebrachii) into tubes with EDTA and transported
into the laboratory on cooler blocks at about 4-5◦C. Blood
samples were examined by a modiﬁed Knott’s test [7]f o r
detection of circulating mf. After centrifugation, all the
sediment was collected, mf checked by light microscope
(10x magniﬁcation), and the number of mf/1mL of blood
calculated.
Commercial kit (Leucognost-SP) was used for mf iden-
tiﬁcation by histochemical staining of acid phosphatase
activity [15].
3.Results
Before treatment all dogs included in the study were mf
positive (examination no. 1) in the range of 29–2950mf/mL.
AlldogswerefoundpositiveforD. repens circulatingmf.One
month after ﬁrst treatment, no dog was found microﬁlaemic
and lasted negative until the end of the study, that is, 6
months after the last treatment (see Table 1).
4.Discussion
The aim of the clinical study was to assess the eﬃcacy
of imidacloprid and moxidectin combination (Advocate,
Bayer) on microﬁlariaemia level under ﬁeld conditions.
Diroﬁlariosis caused by D. repens is considered to be an
emerging zoonoses [9], and it is spreading from tropical and
subtropical countries to temperate zone. The main source
of human infection is infected mosquitoes which had a
bloodmealonDiroﬁlaria-positive animals,mainlydogs[16].
The prevalence of human diroﬁlariosis rapidly increased in
the last decades, even in areas where the infection was not
expected [16–19]. Humans serve as dead-end hosts, where
usually the parasites do not develop to adult stage [20]
though few cases of circulating mf have been reported in
humans [16, 21].
The prepatency of D. repens infection lasts 6 to 9 months
[22, 23]. Six months of sampling and examination after
treatment were carried out to verify both the microﬁlaricidal
eﬀect and the preventive eﬃcacy of the treatment. One
hundred percent of dogs lasted negative 6 months after last
treatment.Veterinary Medicine International 3
This study was carried out in Czech Republic, a country
that is in a temperate zone, where the ﬁrst autochthonous
case of canine diroﬁlariosis was found in 2006 [5]. During
the following years, D. repens infection spread rapidly in
wider areas, particularly along the main rivers [24].
Dogs can serve as source of infection regardless of
circulating mf amount. On the other hand, longevity of D.
repens leads to accumulation of parasites over years, and it
could increase microﬁlariaemia. Therapy and prevention of
subcutaneous diroﬁlariosis in dogs minimize the frequency
of mf in their blood and dramatically reduce the risk
of transmission. Reduction of infection source for vector
decreases the risk of transmission and the further spread
in dog population. Simultaneously, it poses the only way to
control and inhibit transmission to human. Thus, therapy of
D. repens positive dogs is recommended.
Until now, information about therapy and prevention
of D. repens infection in dogs has been sporadic, and only
few studies have been carried out with a combination of
injectable melarsomine and oral administration of macro-
cyclic lactones, though the actual eﬃcacy was questionable
because of the death of the patient [1, 22].
5.Conclusions
The results of this study showed that a combination of imi-
dacloprid (10–25mg/kg) and moxidectin (2,5–6,25mg/kg)
in spot-on formulation (Advocate, Bayer) was safe and
100% eﬀective in clearing circulating mf from the blood of
naturally infected dogs one month after a single treatment.
The treatment was repeated monthly for 4 consecutive
months, and dogs lasted negative both throughout the
treatment and during the further 6 months of the study.
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